Cash flow Alnylam Pharmaceuticals, Inc.

Equities

ALNY

US02043Q1076

Pharmaceuticals

Market Closed - Nasdaq Other stock markets 21:00:00 23/01/2026 GMT			5-day change	1st Jan Change
357.98 ^USD	-3.25%		-0.36%	-9.98%

01-20	RBC Cuts Price Target on Alnylam Pharmaceuticals to $465 From $500, Keeps Outperform Rating	MT
01-14	Alnylam Pharmaceuticals Insider Sold Shares Worth $1,395,992, According to a Recent SEC Filing	MT

944b18fb6fa.ys-8hu2cAlH1qFfckUR111dRTVqMVYfp5QIPz31RuvY._ojutKHpZBKBkRa20hYYu2UOIzfmZ8CNnFNQhBM_1ZeYteTuuqtJIp_rPA

Published financial data: ALNYLAM PHARMACEUTICALS, INC.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2020	2021	2022	2023	2024
Revenues	493M	844M	1.04B	1.83B	2.25B
Total Revenues	493M	844M	1.04B	1.83B	2.25B
Cost of Goods Sold, Total	78.05M	140M	169M	310M	323M
Gross Profit	415M	704M	869M	1.52B	1.92B
Selling General & Admin Expenses, Total	658M	702M	771M	796M	976M
R&D Expenses	585M	711M	883M	1B	1.13B
Other Operating Expenses, Total	1.24B	1.41B	1.65B	1.8B	2.1B
Operating Income	-828M	-709M	-785M	-282M	-177M
Interest Expense, Total	-84.5M	-143M	-156M	-121M	-142M
Interest And Investment Income	11.81M	1.58M	24.81M	95.56M	122M
Net Interest Expenses	-72.69M	-141M	-131M	-25.66M	-19.87M
Other Non Operating Income (Expenses)	-8.52M	-57.74M	-101M	-109M	-178M
EBT, Excl. Unusual Items	-910M	-908M	-1.02B	-417M	-374M
Gain (Loss) On Sale Of Investments	54.04M	55.7M	-33.31M	-16.94M	-3.02M
Legal Settlements	-	-	-	-	-
Other Unusual Items	-	-	-76.59M	-	-
EBT, Incl. Unusual Items	-856M	-852M	-1.13B	-434M	-377M
Income Tax Expense	2.68M	680K	4.16M	6.72M	-99.22M
Earnings From Continuing Operations	-858M	-853M	-1.13B	-440M	-278M
Net Income to Company	-858M	-853M	-1.13B	-440M	-278M
Net Income - (IS)	-858M	-853M	-1.13B	-440M	-278M
Net Income to Common Incl Extra Items	-858M	-853M	-1.13B	-440M	-278M
Net Income to Common Excl. Extra Items	-858M	-853M	-1.13B	-440M	-278M
Per Share Items
Net EPS - Basic	-7.46	-7.2	-9.3	-3.52	-2.18
Basic EPS - Continuing Operations	-7.46	-7.2	-9.3	-3.52	-2.18
Basic Weighted Average Shares Outstanding	115M	118M	122M	125M	128M
Net EPS - Diluted	-7.46	-7.2	-9.3	-3.52	-2.18
Diluted EPS - Continuing Operations	-7.46	-7.2	-9.3	-3.52	-2.18
Diluted Weighted Average Shares Outstanding	115M	118M	122M	125M	128M
Normalized Basic EPS	-4.94	-4.79	-5.22	-2.08	-1.83
Normalized Diluted EPS	-4.94	-4.79	-5.22	-2.08	-1.83
Supplemental Items
EBITDA	-794M	-661M	-741M	-228M	-120M
EBITA	-828M	-709M	-785M	-282M	-177M
EBIT	-828M	-709M	-785M	-282M	-177M
EBITDAR	-679M	-535M	-723M	-161M	-54.47M
Total Revenues (As Reported)	493M	844M	1.04B	1.83B	2.25B
Effective Tax Rate - (Ratio)	-0.31	-0.08	-0.37	-1.55	26.29
Current Domestic Taxes	61K	293K	-	4.02M	1.6M
Current Foreign Taxes	5.84M	3.15M	5.6M	3.42M	5.94M
Total Current Taxes	5.9M	3.45M	5.6M	7.44M	7.54M
Deferred Domestic Taxes	393K	-	-	-	-
Deferred Foreign Taxes	-3.61M	-2.77M	-1.43M	-713K	-107M
Total Deferred Taxes	-3.22M	-2.77M	-1.43M	-713K	-107M
Normalized Net Income	-569M	-567M	-636M	-260M	-234M
Interest on Long-Term Debt	-	143M	48.37M	14.67M	142M
Supplemental Operating Expense Items
Advertising Expense	-	-	-	-	29.7M
General and Administrative Expenses	-	-	-	-	-
Research And Development Expense From Footnotes	655M	792M	883M	1B	1.13B
Net Rental Expense, Total	115M	126M	17.61M	66.64M	65.74M
Imputed Operating Lease Interest Expense	82.09M	76.45M	9.16M	24.41M	27.5M
Imputed Operating Lease Depreciation	33.07M	49.78M	8.45M	42.23M	38.24M
Stock-Based Comp., R&D Exp. (Total)	60.46M	68.42M	92.16M	97.27M	128M
Stock-Based Comp., G&A Exp. (Total)	-	-	-	-	-
Stock-Based Comp., SG&A Exp. (Total)	79.41M	97.3M	138M	124M	144M
Stock-Based Comp., Other (Total)	-	-	-	-	-
Total Stock-Based Compensation	140M	166M	231M	222M	272M

Fiscal Period: December	2020	2021	2022	2023	2024
Assets
Cash And Equivalents	497M	820M	866M	813M	966M
Short Term Investments	1.38B	1.62B	1.33B	1.63B	1.73B
Total Cash And Short Term Investments	1.87B	2.44B	2.19B	2.44B	2.69B
Accounts Receivable, Total	102M	199M	238M	328M	405M
Other Receivables	500M	-	-	-	-
Total Receivables	602M	199M	238M	328M	405M
Inventory	75.2M	86.36M	129M	89.15M	78.51M
Prepaid Expenses	62.77M	88.08M	133M	126M	117M
Restricted Cash	-	-	-	-	-
Total Current Assets	2.61B	2.81B	2.69B	2.98B	3.3B
Gross Property Plant And Equipment	811M	874M	912M	949M	964M
Accumulated Depreciation	-104M	-140M	-173M	-223M	-270M
Net Property Plant And Equipment	707M	734M	739M	726M	694M
Long-term Investments	-	-	-	-	-
Deferred Tax Assets Long-Term	-	-	-	-	117M
Other Long-Term Assets, Total	85.77M	101M	115M	121M	134M
Total Assets	3.41B	3.64B	3.55B	3.83B	4.24B
Liabilities
Accounts Payable, Total	51.97M	73.43M	98.09M	55.52M	88.42M
Accrued Expenses, Total	299M	372M	514M	655M	795M
Current Portion of Long-Term Debt	13.32M	37.08M	40.29M	54.99M	113M
Current Portion of Leases	36.87M	40.55M	41.97M	41.51M	41.89M
Unearned Revenue Current, Total	127M	149M	42.1M	103M	55.48M
Other Current Liabilities	56.64M	22.84M	31.68M	58.28M	92.31M
Total Current Liabilities	585M	696M	768M	968M	1.19B
Long-Term Debt	1.25B	1.83B	2.27B	2.34B	2.36B
Long-Term Leases	293M	281M	261M	243M	230M
Unearned Revenue Non Current	225M	152M	194M	188M	-
Pension & Other Post Retirement Benefits	5.2M	4.3M	-	-	-
Other Non Current Liabilities	32.71M	94.66M	213M	308M	398M
Total Liabilities	2.39B	3.06B	3.7B	4.05B	4.17B
Common Stock, Total	1.16M	1.2M	1.24M	1.26M	1.29M
Additional Paid In Capital	5.64B	6.06B	6.45B	6.81B	7.39B
Retained Earnings	-4.59B	-5.44B	-6.57B	-7.01B	-7.29B
Comprehensive Income and Other	-43.62M	-33.26M	-44.65M	-23.38M	-34.52M
Total Common Equity	1.02B	588M	-158M	-221M	67.09M
Total Equity	1.02B	588M	-158M	-221M	67.09M
Total Liabilities And Equity	3.41B	3.64B	3.55B	3.83B	4.24B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	117M	120M	124M	126M	129M
ECS Total Common Shares Outstanding	116M	120M	124M	126M	129M
Book Value / Share	8.73	4.89	-1.28	-1.75	0.52
Tangible Book Value	1.02B	588M	-158M	-221M	67.09M
Tangible Book Value Per Share	8.73	4.89	-1.28	-1.75	0.52
Total Debt	1.59B	2.19B	2.61B	2.68B	2.74B
Net Debt	-282M	-250M	420M	243M	48.92M
Debt Equivalent of Unfunded Proj. Benefit Obligation	5.2M	4.3M	-	-	-
Debt Equivalent Oper. Leases	921M	1.01B	141M	533M	526M
Account Code - Inventory Valuation	5	5	5	5	5
Inventories - Raw Materials, Total	-	-	-	-	-
Inventories - Work In Process, Total	-	-	-	-	-
Inventories - Finished Goods, Total	-	-	-	-	-
Land - (BS)	9.08M	9.08M	9.08M	9.08M	9.08M
Buildings, Total	263M	263M	269M	272M	295M
Machinery, Total	120M	138M	173M	203M	225M
Full Time Employees	1.45K	1.66K	2K	2.1K	2.23K

Fiscal Period: December	2020	2021	2022	2023	2024
Net Income	-858M	-853M	-1.13B	-440M	-278M
Depreciation & Amortization - CF	74.44M	89.69M	85.55M	97.03M	56.67M
Depreciation & Amortization, Total	74.44M	89.69M	85.55M	97.03M	56.67M
(Gain) Loss on Sale of Investments - (CF)	-54.04M	-55.7M	33.31M	16.94M	3.02M
Stock-Based Compensation (CF)	140M	166M	231M	222M	272M
Other Operating Activities, Total	95.76M	174M	276M	198M	152M
Change In Accounts Receivable	-56.24M	-102M	-45.6M	-87.94M	-86.55M
Change In Inventories	-35.43M	-26.42M	-34.14M	18.37M	13.59M
Change In Accounts Payable	144M	88.24M	192M	80.84M	91.09M
Change in Unearned Revenues	-43.96M	-50.4M	-65.91M	55.02M	-235M
Change in Other Net Operating Assets	-20.81M	-72.44M	-81.68M	-55.53M	3.23M
Cash from Operations	-615M	-642M	-541M	104M	-8.31M
Capital Expenditure	-70.36M	-76.37M	-72.06M	-62.21M	-34.28M
Investment in Marketable and Equity Securities, Total	-334M	-193M	255M	-270M	-63.25M
Other Investing Activities, Total	-31.2M	-4.36M	-13.19M	-4.44M	-19.32M
Cash from Investing	-436M	-273M	169M	-336M	-117M
Long-Term Debt Issued, Total	200M	500M	1.02B	-	-
Total Debt Issued	200M	500M	1.02B	-	-
Long-Term Debt Repaid, Total	-	-	-881M	-	-
Total Debt Repaid	-	-	-881M	-	-
Issuance of Common Stock	300M	246M	259M	147M	303M
Repurchase of Common Stock	-	-	-	-	-
Other Financing Activities, Total	495M	501M	31M	24.67M	-8.79M
Cash from Financing	995M	1.25B	426M	172M	294M
Foreign Exchange Rate Adjustments	4.92M	-9.02M	-7.43M	6.39M	-15.24M
Net Change in Cash	-50.58M	323M	46.4M	-53.67M	154M
Supplemental Items
Cash Interest Paid	-	24.66M	45.24M	32.12M	67.58M
Cash Income Tax Paid (Refund)	-	-	-	-	14.36M
Levered Free Cash Flow	-777M	97.11M	-403M	147M	198M
Unlevered Free Cash Flow	-724M	187M	-306M	222M	287M
Change In Net Working Capital	351M	-450M	59.25M	-142M	-103M
Net Debt Issued / Repaid	200M	500M	135M	-	-

Fiscal Period: December	2020	2021	2022	2023	2024
Profitability
Return on Assets	-17.85	-12.56	-13.65	-4.78	-2.74
Return on Total Capital	-23.8	-16.46	-18.77	-7.17	-4.19
Return On Equity %	-69.92	-106.31	-526.14	232.4	362.29
Return on Common Equity	-69.92	-106.31	-526.14	232.4	362.29
Margin Analysis
Gross Profit Margin %	84.16	83.4	83.73	83.02	85.62
SG&A Margin	133.55	83.16	74.29	43.52	43.39
EBITDA Margin %	-161.04	-78.3	-71.39	-12.48	-5.35
EBITA Margin %	-168.09	-83.93	-75.68	-15.43	-7.87
EBIT Margin %	-168.09	-83.93	-75.68	-15.43	-7.87
Income From Continuing Operations Margin %	-174.15	-101.01	-109.04	-24.08	-12.37
Net Income Margin %	-174.15	-101.01	-109.04	-24.08	-12.37
Net Avail. For Common Margin %	-174.15	-101.01	-109.04	-24.08	-12.37
Normalized Net Income Margin	-115.35	-67.2	-61.28	-14.24	-10.41
Levered Free Cash Flow Margin	-157.68	11.5	-38.87	8.01	8.8
Unlevered Free Cash Flow Margin	-146.97	22.09	-29.48	12.16	12.75
Asset Turnover
Asset Turnover	0.17	0.24	0.29	0.5	0.56
Fixed Assets Turnover	0.73	1.17	1.41	2.5	3.17
Receivables Turnover (Average Receivables)	6.78	5.61	4.75	6.46	6.13
Inventory Turnover (Average Inventory)	1.19	1.73	1.57	2.85	3.86
Short Term Liquidity
Current Ratio	4.47	4.04	3.51	3.08	2.78
Quick Ratio	4.23	3.79	3.16	2.86	2.61
Operating Cash Flow to Current Liabilities	-1.05	-0.92	-0.7	0.11	-0.01
Days Sales Outstanding (Average Receivables)	54	65.06	76.79	56.47	59.67
Days Outstanding Inventory (Average Inventory)	308.43	210.39	232.78	128.23	94.88
Average Days Payable Outstanding	192.34	151.24	148.06	103.6	84.22
Cash Conversion Cycle (Average Days)	170.09	124.21	161.51	81.1	70.33
Long Term Solvency
Total Debt/Equity	156.73	371.59	-1.65K	-1.22K	4.09K
Total Debt / Total Capital	61.05	78.8	106.45	108.96	97.61
LT Debt/Equity	151.79	358.39	-1.6K	-1.17K	3.86K
Long-Term Debt / Total Capital	59.12	76	103.1	105.04	92.1
Total Liabilities / Total Assets	70.17	83.86	104.46	105.76	98.42
EBIT / Interest Expense	-9.8	-4.95	-5.03	-2.33	-1.25
EBITDA / Interest Expense	-8.03	-3.74	-4.64	-1.33	-0.38
(EBITDA - Capex) / Interest Expense	-8.86	-4.27	-5.1	-1.85	-0.63
Total Debt / EBITDA	-2.35	-4.09	-3.61	-16.61	-50.36
Net Debt / EBITDA	0.42	0.47	-0.58	-1.51	-0.9
Total Debt / (EBITDA - Capex)	-2.13	-3.58	-3.29	-11.99	-30.91
Net Debt / (EBITDA - Capex)	0.38	0.41	-0.53	-1.09	-0.55
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	124.28	71.31	22.88	76.23	22.97
Gross Profit, 1 Yr. Growth %	113.06	69.75	23.36	74.75	26.81
EBITDA, 1 Yr. Growth %	-13.94	-16.7	12.03	-69.2	-47.3
EBITA, 1 Yr. Growth %	-11.82	-14.46	10.78	-64.06	-37.31
EBIT, 1 Yr. Growth %	-11.82	-14.46	10.78	-64.06	-37.31
Earnings From Cont. Operations, 1 Yr. Growth %	-3.14	-0.64	32.64	-61.08	-36.82
Net Income, 1 Yr. Growth %	-3.14	-0.64	32.64	-61.08	-36.82
Normalized Net Income, 1 Yr. Growth %	1.46	-0.2	12.03	-59.04	-10.14
Diluted EPS Before Extra, 1 Yr. Growth %	-7.96	-3.54	29.11	-62.1	-38.18
Accounts Receivable, 1 Yr. Growth %	138.11	93.89	19.84	37.75	23.65
Inventory, 1 Yr. Growth %	33.46	14.84	49.33	-30.87	-11.93
Net Property, Plant and Equip., 1 Yr. Growth %	9.3	3.84	0.68	-1.74	-4.39
Total Assets, 1 Yr. Growth %	42.25	6.93	-2.66	7.99	10.71
Tangible Book Value, 1 Yr. Growth %	-29.36	-42.12	-126.9	39.45	-130.41
Common Equity, 1 Yr. Growth %	-29.36	-42.12	-126.9	39.45	-130.41
Cash From Operations, 1 Yr. Growth %	120.87	4.35	-15.65	-119.24	-107.98
Capital Expenditures, 1 Yr. Growth %	-49.8	8.54	-5.65	-13.67	-44.9
Levered Free Cash Flow, 1 Yr. Growth %	86.88	-112.5	-515.25	-136.34	91.09
Unlevered Free Cash Flow, 1 Yr. Growth %	74.18	-125.75	-263.96	-172.7	59.8
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	156.5	96.01	45.08	47.16	47.21
Gross Profit, 2 Yr. CAGR %	138.2	90.18	44.71	46.82	48.86
EBITDA, 2 Yr. CAGR %	-0.36	-15.34	-3.4	-41.26	-59.71
EBITA, 2 Yr. CAGR %	0.84	-13.15	-2.65	-36.9	-52.53
EBIT, 2 Yr. CAGR %	0.84	-13.15	-2.65	-36.9	-52.53
Earnings From Cont. Operations, 2 Yr. CAGR %	6.16	-1.9	14.8	-28.15	-50.41
Net Income, 2 Yr. CAGR %	6.16	-1.9	14.8	-28.15	-50.41
Normalized Net Income, 2 Yr. CAGR %	9.1	0.63	5.74	-32.26	-39.33
Diluted EPS Before Extra, 2 Yr. CAGR %	-0.7	-5.78	11.59	-30.03	-51.58
Accounts Receivable, 2 Yr. CAGR %	133.65	114.87	52.43	28.48	30.51
Inventory, 2 Yr. CAGR %	76.76	23.8	30.95	1.6	-21.98
Net Property, Plant and Equip., 2 Yr. CAGR %	48.44	6.54	2.25	-0.54	-3.07
Total Assets, 2 Yr. CAGR %	47.09	23.33	2.02	2.53	9.34
Tangible Book Value, 2 Yr. CAGR %	-11.65	-36.06	-60.54	-38.75	-34.88
Common Equity, 2 Yr. CAGR %	-11.65	-36.06	-60.54	-38.75	-34.88
Cash From Operations, 2 Yr. CAGR %	4.55	51.81	-6.18	-59.71	-87.61
Capital Expenditures, 2 Yr. CAGR %	-25.53	-26.18	1.2	-9.75	-31.03
Levered Free Cash Flow, 2 Yr. CAGR %	28.56	-51.67	-27.96	22.83	-33.27
Unlevered Free Cash Flow, 2 Yr. CAGR %	24.11	-33.03	-35.03	9.17	-9.11
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	76.32	124.21	67.75	54.8	38.61
Gross Profit, 3 Yr. CAGR %	66.47	112.77	64.62	54.1	39.82
EBITDA, 3 Yr. CAGR %	17.58	-6.14	-7.05	-34.01	-43.35
EBITA, 3 Yr. CAGR %	18.32	-4.54	-5.81	-30.16	-37.04
EBIT, 3 Yr. CAGR %	18.32	-4.54	-5.81	-30.16	-37.04
Earnings From Cont. Operations, 3 Yr. CAGR %	20.47	3.85	8.48	-19.95	-31.16
Net Income, 3 Yr. CAGR %	20.47	3.85	8.48	-19.95	-31.16
Normalized Net Income, 3 Yr. CAGR %	22.99	5.91	4.3	-22.92	-25.57
Diluted EPS Before Extra, 3 Yr. CAGR %	11.25	-1.66	4.65	-22.13	-32.86
Accounts Receivable, 3 Yr. CAGR %	44.42	119.56	76.87	47.37	26.85
Inventory, 3 Yr. CAGR %	-	53.1	31.78	5.83	-3.13
Net Property, Plant and Equip., 3 Yr. CAGR %	57.19	31.77	4.55	0.9	-1.84
Total Assets, 3 Yr. CAGR %	19.54	32.26	13.98	3.98	5.19
Tangible Book Value, 3 Yr. CAGR %	-16.83	-23.27	-52.09	-39.9	-51.5
Common Equity, 3 Yr. CAGR %	-16.83	-23.27	-52.09	-39.9	-51.5
Cash From Operations, 3 Yr. CAGR %	17.12	4.48	24.81	-44.67	-76.52
Capital Expenditures, 3 Yr. CAGR %	-12.27	-15.57	-19.89	-4.02	-23.44
Levered Free Cash Flow, 3 Yr. CAGR %	33.24	-40.89	-1.02	-42.66	26.78
Unlevered Free Cash Flow, 3 Yr. CAGR %	30.15	-26.53	-9.74	-32.55	15.39
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	64.35	78.07	63.09	89.45	59.21
Gross Profit, 5 Yr. CAGR %	58.78	71.72	57.4	83.42	58.13
EBITDA, 5 Yr. CAGR %	23.44	10.06	8.69	-22.18	-33.47
EBITA, 5 Yr. CAGR %	22.85	10.79	9.44	-19.11	-28.39
EBIT, 5 Yr. CAGR %	22.85	10.79	9.44	-19.11	-28.39
Earnings From Cont. Operations, 5 Yr. CAGR %	24.23	15.77	18.17	-10.38	-20.68
Net Income, 5 Yr. CAGR %	24.23	15.77	18.17	-10.38	-20.68
Normalized Net Income, 5 Yr. CAGR %	25.68	16.83	15.77	-11.43	-16.03
Diluted EPS Before Extra, 5 Yr. CAGR %	16.67	8.49	11.39	-14.18	-23.11
Accounts Receivable, 5 Yr. CAGR %	65.3	53.46	47.57	77.2	56.62
Inventory, 5 Yr. CAGR %	-	-	-	29.94	6.86
Net Property, Plant and Equip., 5 Yr. CAGR %	90.98	44.97	32.35	17.75	1.43
Total Assets, 5 Yr. CAGR %	19.7	23.6	12.2	19.45	12.1
Tangible Book Value, 5 Yr. CAGR %	-4.28	-8.56	-38.28	-29.88	-45.83
Common Equity, 5 Yr. CAGR %	-4.28	-8.56	-38.28	-29.88	-45.83
Cash From Operations, 5 Yr. CAGR %	26.59	15.84	7.17	-28.63	-50.46
Capital Expenditures, 5 Yr. CAGR %	40.29	3.42	-7.11	-13.29	-24.55
Levered Free Cash Flow, 5 Yr. CAGR %	40.78	-12.41	4.18	-20.8	-13.8
Unlevered Free Cash Flow, 5 Yr. CAGR %	38.81	-0.2	-1.43	-13.92	-7.18